Erlotinib Viatris 150 mg filmom obložene tablete
| Name | Erlotinib Viatris 150 mg filmom obložene tablete |
|---|---|
| Marketing Authorisation Number | HR-H-088638189 |
| Active Substance | erlotinibklorid |
| Composition | jedna filmom obložena tableta sadrži 150 mg erlotiniba (u obliku erlotinibklorida) |
| Pharmaceutical Form | filmom obložena tableta |
| Packaging [MA Number for Packaging] | 30 tableta u blisteru s jediničnom dozom, u kutiji [HR-H-088638189-01] 30 tableta u blisteru, u kutiji [HR-H-088638189-02] |
| Manufacturer | Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Viatris Limited, Damastown Industrial Park, Mulhuddart, Dublin, Irska |
| Marketing Authorisation Date | 22.03.2024 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/127 |
| Registration Number | 381-12-01/171-24-31 |
| Prescription | na recept |
| Type of prescription | ograničeni recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | L01EB02 |
| Medicinal product marketed in the Croatia | Nestašica |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
